Tuya Reports Third Quarter 2024 Unaudited Financial Results

SANTA CLARA, Calif., Nov. 19, 2024 /PRNewswire/ — Tuya Inc. ("Tuya" or…

Achyuta Samanta Honoured With FIVB Grand Cross Award

BHUBANESWAR, India, Nov. 19, 2024 /PRNewswire/ — The Founder of KIIT and…

Supermicro Delivers Direct-Liquid-Optimized NVIDIA Blackwell Solutions

Supermicro’s SuperClusters with NVIDIA HGXTM B200 8-GPU, NVIDIA GB200, NVL4, and NVL72…

BLUETTI and UN-Habitat Forge Partnership to Promote Clean Energy and Sustainable Development Across Africa

LAS VEGAS, Nov. 19, 2024 /PRNewswire/ — BLUETTI, a global leader in…

Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Convergence 2024

78-Week results from Phase III randomized controlled trial (RCT) including switching data…

TCL CSOT Launches APEX Brand and Announces Mass Production of Inkjet Printing OLED at DTC2024 Global Display Tech-ecosystem Conference

GUANGZHOU, China, Nov. 19, 2024 /PRNewswire/ — On November 16th, the 2024…

TCL CSOT Unveils APEX: An Advanced Display Technology Brand to Redefine Visual Experience

GUANGZHOU, China, Nov. 19, 2024 /PRNewswire/ — TCL CSOT, a global leader…

TCL CSOT Announces the Mass Production of Inkjet Printing OLED at DTC2024

GUANGZHOU, China, Nov. 19, 2024 /PRNewswire/ — On November 16th, the 2024 TCL…